"Hepatology Digest" : How do you prevent the progression of liver fibrosis and cirrhosis?
《国际肝病》：如何防止肝纤维化和肝硬化？
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Conclusion liver mass in patients with liver cirrhosis is related to hepatic hemodynamics, indices for liver fibrosis and liver pathology.
结论肝硬化患者肝组织质量与肝血流动力学、肝纤维化指标及病理分期有关。
The condition can lead to hepatitis, fibrosis, cirrhosis and liver failure.
这种情况可能导致肝炎，肝纤维化，肝硬化和肝功能衰竭。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
Ongoing liver damage with liver cell necrosis followed by fibrosis and hepatocyte regeneration results in cirrhosis.
肝硬化是肝细胞坏死后，肝纤维化和肝细胞再生所致。
The liver injury with chronic alcoholism leads to fibrosis and regeneration of the hepatocytes in nodules. This firm, nodular appearance of the liver as seen here is called cirrhosis.
细胞损伤时细胞内的沉积物是多种多样的。肝细胞损伤尤其是长期酒精性损伤导致脂蛋白大量异常转运从而使脂质在肝实质细胞内大量沉积。
The liver injury being caused by various harmful factors were manifested as hepatic necrosis, fatty liver, cholestasis, liver fibrosis, liver cirrhosis and liver cancer and so on.
各种有害因素所致的肝损伤可表现为肝坏死、脂肪肝、胆汁郁积、肝纤维化、肝硬化及肝癌等。
And there was no relationship in patients with liver cirrhosis. IGF-1 might be related with liver damage and hepatic fibrosis in patients with CHB.
CHB患者血清igf - 1水平异常与肝脏的损害相关，而且可能与CHB患者肝脏纤维组织增生相关联。
Immune-tolerant phase patients only very light or no liver fibrosis progression, and immune clearance period is liver cirrhosis of high-risk period.
免疫耐受期患者只有很轻或没有肝纤维化进展，而免疫清除期是肝硬化的高发时期。
Immune-tolerant phase patients only very light or no liver fibrosis progression, and immune clearance period is liver cirrhosis of high-risk period.
免疫耐受期患者只有很轻或没有肝纤维化进展，而免疫清除期是肝硬化的高发时期。
应用推荐